Bought
Maintained
Sold
Other funds holding PFE
Bayban's PFE Position: Q3 2026 in Review
Bayban increased its Pfizer (PFE) stake by 126% in Q3 2026, buying an estimated $132K and bringing the position to 8,919 shares worth $254K. The position accounts for 0.19% of the portfolio, ranked #88.
Bayban first reported a position in PFE in Q4 2025 and has held it in 4 quarters since. 2,915 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Bayban held 8,919 shares of Pfizer worth $254K as of Q3 2026.
- Bayban bought 4,974 Pfizer shares in Q3 2026, an estimated $132K.
- Pfizer made up 0.19% of Bayban's portfolio in Q3 2026, its #88 holding.
- Bayban first reported a position in Pfizer in Q4 2025 and has held it in 4 quarters since.
- 2,915 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.